What question did this study set out to answer?

The main aim is to investigate how ranibizumab treatment affects visual perception in patients with diabetic macular edema.

January 24, 20260 citations

View Full Paper

Subjective Changes in Vision of Patients with Diabetic Macular Edema Treated with Ranibizumab.

KTKristína Anna Ivkovičová Tarková ZUZuzana Urbanová LHLibor Hejsek

Key Points

The main aim is to investigate how ranibizumab treatment affects visual perception in patients with diabetic macular edema.
1-year observational study
Treatment with ranibizumab via intravitreal injection
Assessment of objective parameters including LS, CRT, and TMV
Objective vision parameters improved after treatment
Subjective visual perception changes improved across all monitored parameters

Abstract

We determined that anti-VEGF ranibizumab treatment improved objective parameters after one year of intravitreal therapy in LS, CRT and TMV. Subjective changes in visual perception improved in all the monitored parameters after one year of treatment.

KI fragen

Bookmark

View Full Paper

Cite This Study

Tarková et al. (Wed,) studied this question.

synapsesocial.com/papers/6974616cbb9d90c67120b48e https://doi.org/https://doi.org/10.31348/2025/43

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

KI fragen

Bookmark

View Full Paper